A STUDY TO ASSESS THE HB VACCINATION STATUS OF THE PATIENTS ATTENDING NIUM, BANGALORE
Background: Hepatitis-B is a disease which is becoming vulnerable and contributing a large man power as well as economical loss worldwide. It is a serious and common infectious disease of the liver affecting millions of people worldwide. The best way to culminate it, is, creating awareness about the disease and administration of vaccination in the general population, in children through immunization schedule. The present study focuses to see the level of vaccination status of the population of Bangalore city.
Objectives: The main objective of the study the prevalence of HB vaccination status of the Patients Attending National Institute of Unani Medicine, Bangalore.
Materials and Methods: The present study was a hospital based cross-sectional study. In this study every 10th patient from the registration register of NIUM hospital was taken and enquired about the HB vaccination, till the statistically calculated sample size of 903 was obtained.
Results: The study revealed that the people of Bangalore city, which is counted among the cities having high literacy rates in India, merely 15 i.e. 2% out of 903 people had found vaccinated against HB virus infection.
Conclusion: In the present the study 15 i.e. 2% out of 903 people were found vaccinated against HBV infection. The overall carrier rate is often quoted as 4.7% among the populations studies based on meta analysis. The outcome of this study shows that people of Bangalore city were not found much aware about the vaccination and are at high risk to develop and spread of the disease. More studies with larger sample size should be conducted to refine these results so that more awareness programs should be conducted to create the awareness among the people of Bangalore city.
Anonymous. World Health Organisation, Department of Communicable Disease. Surveillance and Response Hepatitis B. Report 2002 No. WHO/CSR/LYO/2002.2.
Anonymous. CDC (2006). A comprehensive immunization strategy to eliminate transmission of hepatitis-B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part 11: immunization of adults. MMWR: 55(RR-16). Recommendations and Reports December 2006;55(RR16):1.
Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases. 6th edi. Philadelphia: Elsevier publications; 2005:443-444.
Armstrong D, Cohen J. Infectious Diseases. 1st edi. Vol.1. London: Harcourt Publishers Ltd; 1999:39.1-39.12.
Mahoney FJ. Update on Diagnosis, Management and Prevention of Hepatitis-B Virus Infection. Clinical Microbiology Reviews 1999;12(2):351-366.
HBsAg [internet] cited 2010 June 28. Available from http://en.wikipedia.org/wiki/Antigen.
Wilson RA. Viral Hepatitis. New York: Marcel Dekker; 1997:85-117.
Jain A K, Mittal S.K, Ramji S, Chakravarti A. Hepatitis-B Vaccine in the EPI Schedule. Indian Journal of Paediatrics 2005;72(8):661-664.
Chen DS. Toward Elimination and Eradication of Hepatitis-B. Journal of Gastroenterology and Hepatology 2010;25:19-25.
Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis-B Viral Infection: Epidemiology and Vaccination. Epidemiological Reviews 2006;28:112-125.
Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis SM. A mathematical model to estimate global Hepatitis-B disease burden and vaccination impact. International Journal of Epidemiology, 2005;34:1329-1339.
Carey W D. The Prevalence and Natural History of Hepatitis-B in the 21st Century. Cleveland Clinic Journal of Medicine 2009;76(3):52-55.
Kant L, Hall AJ. Epidemiology of Childhood Hepatitis in India: Vaccination Related Issues. Indian Journal of Paediatrics 1995;62:635-653.
Sarin S K. HBV prevalence, Natural History, and Treatment in India and Indian Americans in United States. Current hepatitis reports 2009;8:31-38.
Mann A, Arora U. Prevalence of Hepatitis-B Virus, Hepatitis-C Virus, and HIV in Patients with Chronic Liver Disease in Amritsar. JIACM 2007;8(1):29-37.
Khan MA, Ashraf M, Rehman A, Ali A, Ashraf A, Ditta A. Prevalence of HBV, HCV, HIV in Blood Donors at Liyaqatpur. Professional Medical Journal 2006;13(1):23-26.
Feldman M, Sleisenger MH, Scharschmidt BF. Sleisenger and Fordtran’s Gastrointestinal and liver Disease. Vol.2. 6th edi. WB Sounders Company; 1998:1123-1170.
Sherlock S, Dooley J. Disease of the Liver and Biliary System.10th edition. London: Blackwell Science Ltd; 2002:274-286.
Moxon ER. Modern Vaccines Current Practice and New Approaches. London: Edward Arnold; 1990:75-83.
Batham A, Narula D, Toteja T, Sreeniwas V, Pulyel JM. Systematic Review and Meta-Analysis of Prevalence of Hepatitis-B in India. Indian Paediatrics September 2007; 44:633-674.
Sudan SS, Sharma RK. Prevalence of Hepatitis-B and C in CRF Patients on Maintenance Haemodialysis [internet] cited 2010 April. Available from http://www.bhj.org/journal/2003_4502_april/index.htm.
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 3.0 License.